Guo Yi-Chen, Cao Hao-Di, Lian Xiao-Fen, Wu Pei-Xian, Zhang Fan, Zhang Hua, Lu Dong-Hui
Department of Endo-crinology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Department of Endocrinology, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong Province, China.
World J Diabetes. 2023 Nov 15;14(11):1621-1631. doi: 10.4239/wjd.v14.i11.1621.
Diabetes mellitus (DM) and obesity have become two of the most prevalent and challenging diseases worldwide, with increasing incidence and serious complications. Recent studies have shown that noncoding RNA (ncRNA) and epigenetic regulation play crucial roles in the pathogenesis of DM complicated by obesity. Identification of the involvement of ncRNA and epigenetic regulation in the pathogenesis of diabetes with obesity has opened new avenues of investigation. Targeting these mechanisms with small molecules or RNA-based therapies may provide a more precise and effective approach to diabetes treatment than traditional therapies. In this review, we discuss the molecular mechanisms of ncRNA and epigenetic regulation and their potential therapeutic targets, and the research prospects for DM complicated with obesity.
糖尿病(DM)和肥胖已成为全球最普遍且最具挑战性的两种疾病,其发病率不断上升且并发症严重。最近的研究表明,非编码RNA(ncRNA)和表观遗传调控在肥胖合并糖尿病的发病机制中起关键作用。确定ncRNA和表观遗传调控参与肥胖相关性糖尿病的发病机制,为研究开辟了新途径。与传统疗法相比,用小分子或基于RNA的疗法靶向这些机制可能为糖尿病治疗提供更精确有效的方法。在本综述中,我们讨论了ncRNA和表观遗传调控的分子机制及其潜在治疗靶点,以及肥胖合并糖尿病的研究前景。